Cargando…
Use of Spironolactone in SARS-CoV-2 ARDS Patients
Autores principales: | Dumanlı, Güleren Yartaş, Dilken, Olcay, Ürkmez, Seval |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Anaesthesiology and Intensive Care Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279869/ https://www.ncbi.nlm.nih.gov/pubmed/32551456 http://dx.doi.org/10.5152/TJAR.2020.569 |
Ejemplares similares
-
Effect of prone positioning on end-expiratory lung volume, strain and oxygenation change over time in COVID-19 acute respiratory distress syndrome: A prospective physiological study
por: Dilken, Olcay, et al.
Publicado: (2022) -
Proteomic profiling of lung diffusion impairment in the recovery stage of SARS‐CoV‐2–induced ARDS
por: García‐Hidalgo, María C., et al.
Publicado: (2022) -
Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020) -
Low hemodynamic impact of moderate ARDS caused by SARS-CoV2
por: Ioan, Ana-Maria, et al.
Publicado: (2023) -
Low hemodynamic impact of moderate ARDS caused by SARS-CoV2
por: Ioan, Ana-Maria, et al.
Publicado: (2023)